Diadema Partners’s Elevation Oncology ELEV Stock Holding History

Diadema Partners’s Portfolio ELEV Stock Details ELEV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-362,935	Closed	-$133K	–	142
2025 Q2	$133K	Buy	+362,935	New	+$121K	0.04%	88

Other funds holding ELEV

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Diadema Partners's ELEV Position: Q3 2025 in Review

Diadema Partners sold out of Elevation Oncology (ELEV) in Q3 2025, closing a stake of 362,935 shares — an estimated $133K sold.

Diadema Partners first reported a position in ELEV in Q2 2025 and held it in 1 quarter. The position peaked at $133K in Q2 2025. 1 fund tracked by Wall St. Rank holds ELEV as of Q3 2025.

Diadema Partners reported no remaining Elevation Oncology position as of Q3 2025 after selling out during the quarter.
Diadema Partners sold 362,935 Elevation Oncology shares in Q3 2025, an estimated $133K.
Diadema Partners first reported a position in Elevation Oncology in Q2 2025 and held it in 1 quarter.
Diadema Partners's Elevation Oncology position peaked at $133K in Q2 2025.
1 fund tracked by Wall St. Rank held Elevation Oncology as of Q3 2025.

Based on Diadema Partners's 13F filing for Q3 2025, filed 14 Nov 2025.